User profiles for Hiromu Tanaka

Hiromu Tanaka

The University of Tokyo
Verified email at ms.u-tokyo.ac.jp
Cited by 799

Cytokeratin 19 expression in hepatocellular carcinoma predicts early postoperative recurrence

…, T Shuto, M Ogawa, H Tanaka, S Tanaka… - Cancer …, 2003 - Wiley Online Library
Clinicopathologic features and postoperative outcomes were investigated for patients who
underwent curative surgery for biliary marker (CK7 and CK19)‐positive hepatocellular …

[HTML][HTML] Single-cell analyses and host genetics highlight the role of innate immune cells in COVID-19 severity

…, Y Naito, A Takuwa, F Sugihara, K Tanaka… - Nature …, 2023 - nature.com
Mechanisms underpinning the dysfunctional immune response in severe acute respiratory
syndrome coronavirus 2 infection are elusive. We analyzed single-cell transcriptomes and T …

Effects of Long-Term Postoperative Interferon-α Therapy on Intrahepatic Recurrence after Resection of Hepatitis C Virus–Related Hepatocellular Carcinoma: A …

…, S Nishiguchi, K Hirohashi, H Tanaka… - Annals of internal …, 2001 - acpjournals.org
Background: Interferon therapy decreases the incidence of hepatocellular carcinoma in patients
with chronic hepatitis C. Objective: To evaluate effects of interferon-α on recurrence after …

Incidence and management of bile leakage after hepatic resection for malignant hepatic tumors

S Tanaka, K Hirohashi, H Tanaka, T Shuto… - Journal of the American …, 2002 - Elsevier
BACKGROUND: Bile leakage is one of the frequent and disturbing complications of hepatic
resection. STUDY DESIGN: Clinical records of the 363 patients who underwent hepatic …

Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma

…, H Tanaka, O Yamazaki, K Hirohashi, T Tanaka - Cancer …, 2004 - Wiley Online Library
Although hepatitis C virus (HCV)‐related cirrhosis has been suggested as a risk factor for
intrahepatic cholangiocarcinoma (ICC), few sizeable studies have tested this hypothesis. We …

[HTML][HTML] DOCK2 is involved in the host genetics and biology of severe COVID-19

…, H Nishihara, Y Shirai, K Sonehara, H Tanaka… - Nature, 2022 - nature.com
Identifying the host genetic factors underlying severe COVID-19 is an emerging challenge 1
, 2 , 3 , 4 – 5 . Here we conducted a genome-wide association study (GWAS) involving 2,393 …

Consecutive oral administration of Bifidobacterium longum MM‐2 improves the defense system against influenza virus infection by enhancing natural killer cell …

…, T Takahashi, K Oishi, H Tanaka… - Microbiology and …, 2015 - Wiley Online Library
Bifidobacterium, one of the major components of intestinal microflora, shows anti‐influenza
virus (IFV) potential as a probiotic, partly through enhancement of innate immunity by …

Regulation of the plasma cell transcription factor Blimp-1 gene by Bach2 and Bcl6

K Ochiai, A Muto, H Tanaka, S Takahashi… - International …, 2008 - academic.oup.com
B lymphocyte-induced maturation protein 1 (Blimp-1) is a key regulator for plasma cell
differentiation. Prior to the terminal differentiation into plasma cells, Blimp-1 expression is …

Effect of viral status on recurrence after liver resection for patients with hepatitis B virus–related hepatocellular carcinoma

S Kubo, K Hirohashi, H Tanaka… - … Journal of the …, 2000 - Wiley Online Library
BACKGROUND Risk factors for recurrence after resection of hepatitis B virus (HBV)‐related
hepatocellular carcinoma (HCC) require more precise definition. METHODS Forty patients …

Case series of 17 patients with cholangiocarcinoma among young adult workers of a printing company in J apan

…, Y Matsumura, T Yamada, H Tanaka… - Journal of Hepato …, 2014 - Wiley Online Library
Background An outbreak of cholangiocarcinoma occurred among workers in the offset color
proof‐printing department at a printing company in J apan. The aim of this study was to …